Literature DB >> 26975061

[CROATIAN GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF BENIGN PAROXYSMAL POSITIONAL VERTIGO (BPPV)].

Sinisa Maslovara, Silva Butković-Soldo, Petar Drvis, Marina Roje-Bedeković, Robert Trotić, Srećko Branica, Mario Habek, Tereza Cvjetko, Tihana Vesligaj, Ivan Adamec, Tereza Gabelić, Stjepan Jurić, Andrijana Vceva, Zeljko Vranjes, Ingrid Sarić, Olivera Cejić, Tihomir Zivić.   

Abstract

BPPV is generally the most common cause of vertigo, caused by a pinch-off of tiny calcium carbonate crystals (called the otoconia or the otoliths) from the macula utriculi, most frequently due to the degenerative processes or a trauma, whereby the crystals, under the action of gravity in certain head positions coinciding with its direction, arrive to some of the semicircular canals, usually the posterior one, due to the existent anatomical circumstances and relationships, thus creating an inadequate stimulus of the cupular senses while floating through the endolymph and provoking symptoms of a strong and short-term dizziness. Two main clinical forms can be distinguished: canalolythiasis, with an accommodation of otolithic debris in the semicircular canal, and cupulolythiasis, with their location immediately next to the cupular sense. The diagnosis is established by a positive positioning test, Dix-Hallpike for the posterior and the supine roll for the lateral canal. Although one can expect a spontaneous recovery subsequent to few weeks or months, various methods of otolith repositioning to a less sensitive place lead to a prompt improvement while reducing or withdrawing the symptoms completely. These guidelines are intended for all who treat the BPPV in their work, with an intention to assist in the diagnosis and application of an appropriate therapeutic method.

Entities:  

Mesh:

Year:  2015        PMID: 26975061

Source DB:  PubMed          Journal:  Lijec Vjesn        ISSN: 0024-3477


  1 in total

Review 1.  Economic burden of vertigo: a systematic review.

Authors:  Eva Kovacs; Xiaoting Wang; Eva Grill
Journal:  Health Econ Rev       Date:  2019-12-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.